BIOSTEALTH LIMITED
Significant control: Israel Gbati (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Biostealth Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
BIOSTEALTH LIMITED is an active private limited company (company number 10836475) incorporated on 27 June 2017, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 June 2025, showing net assets of −£196k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 14% on the prior period (−£172k).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Israel Gbati
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Georgios Papanikolaou
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 27 June 20179 yrs ago
- Next accounts due
- 30 March 2027in 158 days
- Confirmation statement due
- 11 July 2027in 261 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 86101
- Hospital activities
- SIC 86900
- Other human health activities
- SIC 87300
- Residential care activities for the elderly and disabled
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£196k | — | — | — | — | — | 3 |
| 30 June 2024 | −£172k | — | — | — | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-196,111 at 30 June 2025
- Incorporated five or more years agoIncorporated 27 June 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 261 days
- Next accounts duein 158 days
- Accounts period endNet liabilities £196k · micro accounts
- Accounts period endNet liabilities £172k · micro accounts
- Incorporated
Similar companies in London
Reminders for BIOSTEALTH LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.